Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).
ClinicalTrials.gov study NCT06550336. IPD Sharing: NO. Countries: 1. Publications: 0.
SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma
ClinicalTrials.gov study NCT06122389. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.
ClinicalTrials.gov study NCT06733610. IPD Sharing: NO. Countries: 1. Publications: 0.
Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)
ClinicalTrials.gov study NCT05833724. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease
ClinicalTrials.gov study NCT00058773. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)
ClinicalTrials.gov study NCT05532722. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
ClinicalTrials.gov study NCT06253520. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
ClinicalTrials.gov study NCT07135466. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
ClinicalTrials.gov study NCT00038376. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
ClinicalTrials.gov study NCT06285825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
ClinicalTrials.gov study NCT02439788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas
ClinicalTrials.gov study NCT06585124. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
ClinicalTrials.gov study NCT05418088. IPD Sharing: NO. Countries: 1. Publications: 0.
Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma
ClinicalTrials.gov study NCT00958854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2
ClinicalTrials.gov study NCT05321147. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)
ClinicalTrials.gov study NCT04141982. IPD Sharing: NO. Countries: 2. Publications: 0.
Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS)
ClinicalTrials.gov study NCT05230680. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients
ClinicalTrials.gov study NCT02809573. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis
ClinicalTrials.gov study NCT06688435. IPD Sharing: NO. Countries: 1. Publications: 0.
Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT06113081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.